U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Advisory: Sublingual and Transmucosal Buprenorphine for Opioid Use Disorder: Review and Update

Gives an overview of data on the use of sublingual and transmucosal buprenorphine for MAT of OUD. Discusses the implications of using MAT in recovery support.

Source
Substance Abuse and Mental Health Services Administration
Link
https://store.samhsa.gov/sites/default/files/d7/priv/sma16-4938.pdf
File Size
.42 MB
Year
Format
Advisory
Terms of Use
Public domain
Topic
Medication Considerations
Audience
Medical Providers
Policymakers and Payers
Use
Training and Education About Substance Use Treatment
Special Collection
MAT Tools and Resources